| Code | 3830C | ||||||||||
| MA number | 69/0129/17-S | ||||||||||
| Product Form: | aer ors 1x30 ml (fľ.skl.hnedá) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Dr. Max Pharma s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 69 - OTORHINOLARYNGOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass bottle | ||||||||||
| Route of admin.: | Oropharyngeal use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 15.05.2017 |
| Pediatric posology: | Yes |
| PIL: |
PIL_Larynox_03/2023.pdf
|
| SPC: |
SPC_Larynox_03/2023.pdf
|
| Safety feature | No |
| Data update: | 14.04.2023 |
